GHRP-6 CJC-1295 DAC Peptide Vial

GHRP-6 CJC-1295 DAC Peptide Vial is a precision-formulated combination peptide product supplied at ≥98% purity, available exclusively for qualified laboratory and scientific research applications. This synergistic dual-peptide blend is engineered to support advanced in vitro and preclinical investigations into growth hormone secretagogue pathways and GHRH analog activity. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Available from Direct Anti Peptide, the GHRP-6 CJC-1295 DAC Peptide Vial combines two well-characterised research peptides into a single lyophilised vial. GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that acts on the growth hormone secretagogue receptor (GHSR), stimulating endogenous growth hormone release from the anterior pituitary gland. CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analog engineered with an extended plasma half-life, enabling prolonged receptor engagement and sustained GH pulse amplification. Together, these two peptides form a complementary research tool widely studied in fields including metabolic biology, endocrinology, body composition research, and cellular recovery science.

Peptide Structure & Amino Acid Sequence

GHRP-6 is a synthetic hexapeptide with the amino acid sequence: His-DTrp-Ala-Trp-DPhe-Lys-NH₂. It functions as a ghrelin mimetic and potent GHSR agonist. CJC-1295 DAC is a 30-amino acid GHRH analog modified at the C-terminus with a lysine-maleimide Drug Affinity Complex linker, which facilitates covalent binding to serum albumin, dramatically extending its biological half-life compared to native GHRH(1-29). The DAC modification is the defining structural feature that differentiates CJC-1295 DAC from non-DAC CJC-1295 formulations, making it a uniquely valuable research compound for long-duration in vitro and preclinical study designs.

Chemical & Physical Characteristics

• Product Name: GHRP-6 CJC-1295 DAC Combination Peptide Vial
• Composition (2.5mg Vial): CJC-1295 DAC = 0.8mg | GHRP-6 = 1.7mg
• Composition (10mg Vial): CJC-1295 DAC = 5mg | GHRP-6 = 5mg
• Appearance: White to off-white lyophilised powder
• Solubility: Soluble in aqueous buffer solutions under laboratory conditions
• Purity: ≥98% by HPLC
• Storage Temperature: −20°C (long-term); 2–8°C (short-term)
• Format: Lyophilised powder in sealed research vial

Purity & Analytical Verification (HPLC & MS)

Every batch of GHRP-6 CJC-1295 DAC Peptide Vial supplied by Direct Anti Peptide undergoes rigorous third-party analytical verification. High-Performance Liquid Chromatography (HPLC) is used to confirm peptide purity at ≥98%, while Mass Spectrometry (MS) validates molecular integrity and confirms the correct molecular weight of both active components. These analytical controls ensure that each vial meets the exacting standards required for reproducible scientific research outcomes.

Quality Control & Lyophilisation Integrity

Lyophilisation (freeze-drying) is employed to maximise the stability and shelf life of this combination peptide vial. The process removes residual moisture under vacuum, preserving peptide structure and bioactivity throughout storage and transit. Each vial is sealed under inert conditions to prevent oxidation and contamination. Batch-specific Certificates of Analysis (CoA) are available upon request, providing full transparency on purity, identity, and quality metrics for every research order.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by trained laboratory professionals in controlled research environments. Appropriate personal protective equipment (PPE), including gloves, lab coat, and eye protection, should be worn when handling lyophilised peptide materials. Standard laboratory biosafety protocols must be observed at all times. This product must not be administered to humans or animals under any circumstances.

Reconstitution, Packaging & Storage

For laboratory reconstitution, researchers should consult peer-reviewed literature and established in vitro protocols relevant to their specific study design. Upon reconstitution in an appropriate aqueous solvent, the solution should be aliquoted and stored at −20°C to prevent degradation. Repeated freeze-thaw cycles should be avoided to maintain peptide integrity. The product is packaged in a sealed, clearly labelled research vial suitable for laboratory handling and storage.

Intended Research Use & Market Positioning

The GHRP-6 CJC-1295 DAC Peptide Vial is positioned as a premium research reagent for scientists investigating growth hormone secretagogue receptor biology, GHRH analog pharmacology, metabolic regulation, body composition mechanisms, and cellular recovery pathways. It is of particular interest in preclinical research areas including sports science, endocrinology, and anti-aging biology. Direct Anti Peptide offers this compound as part of a broad portfolio of high-purity research peptides, enabling researchers to source reliable, analytically verified materials from a single trusted supplier.

Ordering, Availability & Fulfillment

Researchers can buy GHRP-6 CJC-1295 DAC Peptide Vial online directly through Direct Anti Peptide at competitive prices. Both the 2.5mg and 10mg vial formats are available for sale, catering to research programmes of varying scale. Orders are processed promptly, with secure packaging designed to maintain cold-chain integrity during transit. Order now to take advantage of the best price available on this high-purity combination research peptide.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. GHRP-6 CJC-1295 DAC Peptide Vial is sold exclusively as a laboratory research reagent. It is the sole responsibility of the purchasing institution or researcher to ensure compliance with all applicable local, national, and international regulations governing the procurement, storage, and use of research peptides. Direct Anti Peptide makes no claims regarding therapeutic efficacy, safety for human consumption, or suitability for any use outside of controlled laboratory research settings.